Applied DNA Signs Master Services Agreement with Schreiner Group

- August 7th, 2019

Applied DNA Sciences (NASDAQ:APDN) has announced it has signed a Master Services Agreement with Schreiner Group in Germany. As quoted in the press release: Applied DNA will supply its SigNature® DNA forensic molecular tag with Beacon® screening feature for Schreiner MediPharm’s high-end security label portfolio within the Pharmaceutical Industry for product and brand protection of its customers’ … Continued

Applied DNA Sciences (NASDAQ:APDN) has announced it has signed a Master Services Agreement with Schreiner Group in Germany.

As quoted in the press release:

Applied DNA will supply its SigNature® DNA forensic molecular tag with Beacon® screening feature for Schreiner MediPharm’s high-end security label portfolio within the Pharmaceutical Industry for product and brand protection of its customers’ supply chains. Schreiner MediPharm will also provide authentication services to its customers using the Applied DNA SigNify® portable DNA readers now in use at the Schreiner ProSecure competence center, providing security technologies and services to Schreiner MediPharm as well as Schreiner Group’s other business units.

In a joint development, SigNature DNA and Beacon were integrated in Schreiner MediPharm’s security label concepts and processes. These were validated over the last 18 months during which time the labels have undergone exhaustive environmental and reliability testing by both partners.

Dr. James Hayward, President and CEO of Applied DNA, said, “Schreiner MediPharm is an industry leader who brings top notch science and engineering to its pharmaceutical label portfolio with a spirit of innovation. Given the reported and continued high incidence rate of counterfeits within the pharmaceutical supply chain, we firmly believe the forensic SigNature DNA-protected labels will be of significant value in ensuring authentic medicines reach patients.”

Click here to read the full press release.

The newest developments in genetics investing

 
Find out what to watch for in the world of genetics

Leave a Reply

Your email address will not be published. Required fields are marked *